Patents by Inventor Karthik Viswanathan

Karthik Viswanathan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240092921
    Abstract: Antibody molecules that specifically bind to APRIL are disclosed. The antibody molecules can be used to treat, prevent, and/or diagnose disorders, such as IgA nephropathy.
    Type: Application
    Filed: April 24, 2023
    Publication date: March 21, 2024
    Inventors: David William Oldach, James R. Myette, Zachary Shriver, Karthik Viswanathan, Andrew M. Wollacott, Hedy Adari-Hall, Boopathy Ramakrishnan, Gregory Babcock, Jill Yarbrough, Asher Schachter, Mohit Mathur
  • Publication number: 20240095663
    Abstract: A system, method, and computer-readable medium for performing an information technology (IT) ecosystem management and monitoring operation. The IT ecosystem management and monitoring operation includes: providing a sustainability application to an information handling system, the information handling system being located within an IT ecosystem; obtaining sustainability information regarding the information handling system via the sustainability application; providing an IT ecosystem monitoring and management console, the IT ecosystem monitoring and management console comprising an IT ecosystem sustainability system, the IT ecosystem sustainability system comprising a sustainability component; and, communicating between the sustainability component and the sustainability application to perform an IT inventory sustainability planning operation, the communicating providing the sustainability component with the sustainability information regarding the information handling system.
    Type: Application
    Filed: September 16, 2022
    Publication date: March 21, 2024
    Applicant: Dell Products L.P.
    Inventors: Christopher A. Robinette, David O. Garner, John E. Jenne, Vivek Viswanathan Iyer, Karthik Suryanarayanan
  • Publication number: 20240076398
    Abstract: Antibody molecules that specifically bind to C5aR1 are disclosed. The antibody molecules can be used to treat, prevent, and/or diagnose disorders, such as ANCA-vasculitis.
    Type: Application
    Filed: August 18, 2023
    Publication date: March 7, 2024
    Inventors: Karthik Viswanathan, Brian Booth, Boopathy Ramakrishnan, Andrew Wollacott, Gregory Babcock, Zachary Shriver
  • Patent number: 11912781
    Abstract: The present disclosure provides, among other things, two different formats of humanized antibodies against human complement component 5a receptor I. The disclosure also provides a method of treating a subject having dysfunctions of C5a/C5aR1 axis pathway, including but not limited to ANCA-associated vasculitis, comprising administering to the subject in need thereof a an effective amount of antibody or a nucleic encoding an antibodies binding to C5aR1 described herein, and wherein administering results in a decrease in symptoms associated with C5a/C5aR1 associated dysfunction in the subject.
    Type: Grant
    Filed: January 13, 2022
    Date of Patent: February 27, 2024
    Assignee: Visterra, Inc.
    Inventors: Karthik Viswanathan, Brian Booth, Boopathy Ramakrishnan, Andrew Wollacott, Gregory Babcock, Zachary Shriver, Lauren Olinski
  • Patent number: 11890319
    Abstract: Antibody molecule-drug conjugates (ADCs) that specifically bind to lipopolysaccharides (LPS) are disclosed. The antibody molecule-drug conjugates can be used to treat, prevent, and/or diagnose bacterial infections and related disorders.
    Type: Grant
    Filed: January 18, 2018
    Date of Patent: February 6, 2024
    Assignee: VISTERRA, INC.
    Inventors: Zachary Shriver, Obadiah Joseph Plante, Kai Li, Karthik Viswanathan, James C. Delaney, Boopathy Ramakrishnan, Andrew M. Wollacott
  • Patent number: 11858980
    Abstract: Polypeptides, such as antibody molecules and fusion proteins, comprising an Fc region, are disclosed. The polypeptides can be used to treat, prevent, and/or diagnose disorders.
    Type: Grant
    Filed: August 2, 2017
    Date of Patent: January 2, 2024
    Assignee: VISTERRA, INC.
    Inventors: Karthik Viswanathan, Boopathy Ramakrishnan, Brian Booth, Kristin Narayan, Andrew M. Wollacott
  • Publication number: 20230416372
    Abstract: The present disclosure provides, among other things Fc variants that have significantly reduced ADCC, ADCP and CDC function As described herein, the present disclosure is, in part based on identification of novel combinations of mutations that abolish binding to all Fc?RI, Fc?RIIa, Fc?RIIb, Fc?RIIIa, Fc?RIIb, and C1q.
    Type: Application
    Filed: August 29, 2023
    Publication date: December 28, 2023
    Applicant: VISTERRA, INC.
    Inventors: Karthik Viswanathan, Lauren Olinski, Ramki Ramakrishnan, Aditi Deshpande, Gregory Babcock, Zachary Shriver
  • Publication number: 20230365694
    Abstract: The present disclosure provides, among other things Fc variants that have significantly reduced ADCC, ADCP and CDC function As described herein, the present disclosure is, in part based on identification of novel combinations of mutations that abolish binding to all Fc?RI, Fc?RIIa, Fc?RIIb, Fc?RIIIa, Fc?RIIIb, and C1q.
    Type: Application
    Filed: November 2, 2022
    Publication date: November 16, 2023
    Applicant: VISTERRA, INC.
    Inventor: Karthik VISWANATHAN
  • Patent number: 11773179
    Abstract: Antibody molecules that specifically bind to C5aR1 are disclosed. The antibody molecules can be used to treat, prevent, and/or diagnose disorders, such as ANCA-vasculitis.
    Type: Grant
    Filed: January 13, 2021
    Date of Patent: October 3, 2023
    Assignee: VISTERRA, INC.
    Inventors: Karthik Viswanathan, Brian Booth, Boopathy Ramakrishnan, Andrew Wollacott, Gregory Babcock, Zachary Shriver
  • Publication number: 20230264135
    Abstract: Adsorbent materials are disclosed, along with filter elements containing the adsorbent materials methods of using adsorbents to remove siloxane contaminants from a gas stream. The method includes providing an adsorbent material that has been washed with an acid and passing a gas through the adsorbent material so as to reduce siloxane levels in the gas. A filter element for reducing siloxane levels in a gas includes a first adsorbent material, the first adsorbent material comprising an acid-washed adsorbent; and a second adsorbent material, the second adsorbent material comprising an acid-impregnated adsorbent.
    Type: Application
    Filed: April 21, 2023
    Publication date: August 24, 2023
    Inventors: Brian N. Hoang, Gerald Weineck, Karthik Viswanathan, Andrew J. Dallas
  • Publication number: 20230257449
    Abstract: This disclosure relates to binding agents, e.g., antibody molecules, that bind hemagglutinin protein of influenza viruses, and methods of their use.
    Type: Application
    Filed: December 11, 2020
    Publication date: August 17, 2023
    Inventors: Karthik Viswanathan, Brian Booth, Boopathy Ramakrishnan, Andrew M. Wollacott, Gregory Babcock, Zachary Shriver
  • Patent number: 11648501
    Abstract: Adsorbent materials are disclosed, along with filter elements containing the adsorbent materials methods of using adsorbents to remove siloxane contaminants from a gas stream. The method includes providing an adsorbent material that has been washed with an acid and passing a gas through the adsorbent material so as to reduce siloxane levels in the gas. A filter element for reducing siloxane levels in a gas includes a first adsorbent material, the first adsorbent material comprising an acid-washed adsorbent; and a second adsorbent material, the second adsorbent material comprising an acid-impregnated adsorbent.
    Type: Grant
    Filed: May 30, 2020
    Date of Patent: May 16, 2023
    Assignee: Donaldson Company, Inc.
    Inventors: Brian N. Hoang, Gerald Weineck, Karthik Viswanathan, Andrew J. Dallas
  • Publication number: 20220356263
    Abstract: The present disclosure provides, among other things, two different formats of humanized antibodies against human complement component 5a receptor I. The disclosure also provides a method of treating a subject having dysfunctions of C5a/C5aR1 axis pathway, including but not limited to ANCA-associated vasculitis, comprising administering to the subject in need thereof a an effective amount of antibody or a nucleic encoding an antibodies binding to C5aR1 described herein, and wherein administering results in a decrease in symptoms associated with C5a/C5aR1 associated dysfunction in the subject.
    Type: Application
    Filed: January 13, 2022
    Publication date: November 10, 2022
    Inventors: Karthik Viswanathan, Brian Booth, Boopathy Ramakrishnan, Andrew Wollacott, Gregory Babcock, Zachary Shriver
  • Publication number: 20220267418
    Abstract: Antibody molecule-drug conjugates (ADCs) that specifically bind to lipopolysaccharides (LPS) are disclosed. The antibody molecule-drug conjugates can be used to treat, prevent, and/or diagnose bacterial infections and related disorders.
    Type: Application
    Filed: October 8, 2021
    Publication date: August 25, 2022
    Inventors: Obadiah Joseph Plante, James C. Delaney, Karthik Viswanathan, Boopathy Ramakrishnan, Zachary Holmes Shriver, Andrew M. Wollacott
  • Publication number: 20220235124
    Abstract: Antibody molecules that specifically bind to APRIL are disclosed. The antibody molecules can be used to treat, prevent, and/or diagnose disorders, such as IgA nephropathy.
    Type: Application
    Filed: August 31, 2021
    Publication date: July 28, 2022
    Inventors: James R. Myette, Zachary Holmes Shriver, Karthik Viswanathan, Andrew M. Wollacott, Hedy Adari-Hall, Boopathy Ramakrishnan, Gregory Babcock
  • Publication number: 20220204592
    Abstract: This disclosure relates to novel peptide agents, e.g., antibodies and antigen-binding fragments thereof, that bind hemagglutinin protein of influenza viruses, and methods of their use.
    Type: Application
    Filed: August 14, 2020
    Publication date: June 30, 2022
    Inventors: Zachary Shriver, Karthik Viswanathan, Vidya Subramanian, Sasisekharan Raguram
  • Publication number: 20220177553
    Abstract: Antibody molecules that specifically bind to dengue virus are disclosed. In certain embodiments, the antibody molecule bind to dengue virus serotypes DV-1, DV-2, DV-3, and DV-4. The antibody molecules can be used to treat, prevent, and/or diagnose dengue virus.
    Type: Application
    Filed: July 7, 2021
    Publication date: June 9, 2022
    Inventors: Luke Robinson, Zachary Shriver, James R. Myette, Gregory Babcock, Karthik Viswanathan
  • Publication number: 20220089764
    Abstract: Antibody molecules that specifically bind to C5aR1 are disclosed. The antibody molecules can be used to treat, prevent, and/or diagnose disorders, such as ANCA-vasculitis.
    Type: Application
    Filed: January 13, 2021
    Publication date: March 24, 2022
    Inventors: Karthik Viswanathan, Brian Booth, Boopathy Ramakrishnan, Andrew Wollacott, Gregory Babcock, Zachary Shriver
  • Publication number: 20220059184
    Abstract: Disclosed are methods of identifying an epitope on a target polypeptide and methods of identifying a paratope on an antibody.
    Type: Application
    Filed: December 23, 2019
    Publication date: February 24, 2022
    Inventors: Andrew M. Wollacott, Luke Robinson, Boopathy Ramakrishnan, Hamid Tissire, Karthik Viswanathan, Zachary Shriver, Gregory Babcock
  • Patent number: 11168131
    Abstract: Antibody molecule-drug conjugates (ADCs) that specifically bind to lipopolysaccharides (LPS) are disclosed. The antibody molecule-drug conjugates can be used to treat, prevent, and/or diagnose bacterial infections and related disorders.
    Type: Grant
    Filed: November 10, 2016
    Date of Patent: November 9, 2021
    Assignee: VISTERRA, INC.
    Inventors: Obadiah Joseph Plante, James C. Delaney, Karthik Viswanathan, Boopathy Ramakrishnan, Zachary Holmes Shriver, Andrew M. Wollacott